Jade Biosciences is a clinical-stage company developing a pipeline of potentially best-in-class therapies aimed at transforming the standard of care for patients living with autoimmune diseases.
| Website | http://www.jadebiosciences.com |
| Employees | 97 (69 on RocketReach) |
| Founded | 2024 |
| Industry | Biotechnology Research |
| Keywords | Autoimmune Diseases, Therapeutic Development, Biologics, Immunology, Innovative Therapies, Immunotherapy, Drug Discovery, Biotechnology, Pharmaceutical Research, Biopharma, Pipeline Development, Research And Development, Clinical Trials, New Treatments, Translational Research, Precision Medicine, Patient Care, Healthcare, Clinical Stage, Rare Diseases |
| Competitors | Thermo Fisher Scientific, BD Biosciences, Merck Group, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, Inc., Abbott, Promega Corporation, QIAGEN, Fisher Scientific +41 more (view full list) |
Looking for a particular Jade Biosciences employee's phone or email?
Tom Frohlich is the CEO of Jade Biosciences.
69 people are employed at Jade Biosciences.